Federated Hermes, Inc. Biomarin Pharmaceutical Inc Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 19,853 shares of BMRN stock, worth $1.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,853

Previous 20,167 1.56%

Holding current value

$1.26 Million

Previous $1.66 Million 15.96%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$69.02 - $93.84 $21,672 - $29,465	-314 Reduced 1.56%	19,853 $1.4 Million
Q2 2024 Aug 08, 2024	BUY	$74.43 - $92.22 $1.5 Million - $1.86 Million	20,167 New	20,167 $1.66 Million
Q3 2023 Nov 13, 2023	BUY	$85.07 - $94.48 $968,266 - $1.08 Million	11,382 New	11,382 $1.01 Million
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $285,777 - $347,226	-3,998 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$74.28 - $92.69 $744,211 - $928,661	-10,019 Reduced 71.48%	3,998 $308,000
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $641,391 - $818,016	8,943 Added 176.25%	14,017 $1.24 Million
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $8,673 - $9,914	-116 Reduced 2.24%	5,074 $392,000
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $50,591 - $56,809	670 Added 14.82%	5,190 $433,000
Q1 2021 May 13, 2021	SELL	$74.73 - $90.69 $39,382 - $47,793	-527 Reduced 10.44%	4,520 $341,000
Q4 2020 Feb 12, 2021	BUY	$72.61 - $90.2 $96,135 - $119,424	1,324 Added 35.56%	5,047 $443,000
Q3 2020 Nov 12, 2020	SELL	$71.87 - $131.03 $3.59 Million - $6.55 Million	-49,967 Reduced 93.07%	3,723 $283,000
Q2 2020 Aug 13, 2020	BUY	$79.55 - $124.22 $4.27 Million - $6.67 Million	53,690 New	53,690 $6.62 Million
Q1 2019 May 10, 2019	SELL	$84.2 - $98.62 $3,031 - $3,550	-36 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$80.14 - $106.07 $2,885 - $3,818	36 New	36 $3,000
Q3 2018 Nov 13, 2018	SELL	$93.92 - $105.72 $1.33 Million - $1.5 Million	-14,200 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$77.67 - $92.63 $636,894 - $759,566	8,200 Added 136.67%	14,200 $1.15 Million
Q4 2017 Feb 14, 2018	BUY	$80.76 - $95.13 $484,560 - $570,780	6,000	6,000 $0

Others Institutions Holding BMRN

# of Institutions

635

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Biomarin Pharmaceutical Inc Transaction History